Author details

Full Name

Lance D Miller

Affiliation

ORCID

Career Start Year

1999

Papers

153

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36789023	Collagen deposition within brain metastases is associated with leptomeningeal failure after â¿¨cavity-directed radiosurgery.		2023
36217952	Exosomal proteins as a source of biomarkers in colon cancer-derived peritoneal carcinomatosis - A pilot study.	Proteomics - Clinical Applications	2023
37639030	Exploring the Relationship: Low-Grade Appendiceal Mucinous Neoplasms (LAMN) and Mucinous Adenocarcinoma as Phases of the Same Disease Spectrum.		2023
37479733	Single-cell sequencing reveals the landscape of the human brain metastatic microenvironment.	Commun Biol	2023
36973365	Prognostic Mutational Signatures of NSCLC Patients treated with chemotherapy, immunotherapy and chemoimmunotherapy.	NPJ Precis Oncol	2023
37202560	An integrated tumor, immune and microbiome atlas of colon cancer.	Nat Med	2023
36864326	Plasma Exosome Gene Signature Differentiates Colon Cancer from Healthy Controls.		2023
37174093	c-Met Mediated Cytokine Network Promotes Brain Metastasis of Breast Cancer by Remodeling Neutrophil Activities.		2023
36929140	ASO Visual Abstract: Plasma Exosome Gene Signature Differentiates Colon Cancer from Healthy Controls.		2023
35284940	Circulating Immune Bioenergetic, Metabolic, and Genetic Signatures Predict Melanoma Patients' Response to Anti-PD-1 Immune Checkpoint Blockade.	Clinical Cancer Research	2022
35767280	Prognostic attributes of immune signatures in soft tissue sarcomas show differential dependencies on tumor mutational burden.	Cancer	2022
35354808	Phase II trial of cytarabine and mitoxantrone with devimistat in acute myeloid leukemia.	Nat Commun	2022
36418073	Targeting the CD47/thrombospondin-1 signaling axis regulates immune cell bioenergetics in the tumor microenvironment to potentiate antitumor immune response.	J Immunother Cancer	2022
34916656	Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion.	Nature Nanotechnology	2022
35037026	hDirect-MAP: projection-free single-cell modeling of response to checkpoint immunotherapy.	Brief Bioinform	2022
34841601	Comprehensive gene cluster analysis of head and neck squamous cell carcinoma TCGA RNA-seq data defines B cell immunity-related genes as a robust survival predictor.	Head and Neck	2022
34956864	Bulk and Single-Cell Profiling of Breast Tumors Identifies TREM-1 as a Dominant Immune Suppressive Marker Associated With Poor Outcomes.	Front Oncol	2021
34210684	Organoid Platform in Preclinical Investigation of Personalized Immunotherapy Efficacy in Appendiceal Cancer: Feasibility Study.	Clinical Cancer Research	2021
33937015	Comprehensive and Computable Molecular Diagnostic Panel (C2Dx) From Small Volume Specimens for Precision Oncology: Molecular Subtyping of Non-Small Cell Lung Cancer From Fine Needle Aspirates.	Frontiers in Oncology	2021
33446575	Epigenetic and Posttranscriptional Modulation of SOS1 Can Promote Breast Cancer Metastasis through Obesity-Activated c-Met Signaling in African-American Women.	Cancer Research	2021
33093219	Activin A Promotes Regulatory T-cell-Mediated Immunosuppression in Irradiated Breast Cancer.	Cancer Immunol Res	2021
33359676	scLM: Automatic Detection of Consensus Gene Clusters Across Multiple Single-cell Datasets.		2021
33107184	SMARCA4 mutations in KRAS-mutant lung adenocarcinoma: a multi-cohort analysis.	Mol Oncol	2021
34572134	The Presence and Potential Role of ALDH1A2 in the Glioblastoma Microenvironment.	Cells	2021
32518871	<i>APOL1</i> Kidney-Risk Variants Induce Mitochondrial Fission.	Kidney Int Rep	2020
32117236	Transcriptomic Features of T Cell-Barren Tumors Are Conserved Across Diverse Tumor Types.	Front Immunol	2020
32224870	Dysregulated Pyrimidine Biosynthesis Contributes to 5-FU Resistance in SCLC Patient-Derived Organoids but Response to a Novel Polymeric Fluoropyrimidine, CF10.	Cancers (Basel)	2020
31980985	Prognostic Molecular Classification of Appendiceal Mucinous Neoplasms Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.	Annals of Surgical Oncology	2020
31858299	Model of Patient-Specific Immune-Enhanced Organoids for Immunotherapy Screening: Feasibility Study.	Annals of Surgical Oncology	2020
33889540	Multi-Omics Analysis of Brain Metastasis Outcomes Following Craniotomy.	Frontiers in Oncology	2020
32705511	Clinical Implications of Genetic Signatures in Appendiceal Cancer Patients with Incomplete Cytoreduction/HIPEC.	Annals of Surgical Oncology	2020
32529027	and Are Novel Mediators of Resistance to Oncolytic Vesicular Stomatitis Virus in Prostate Cancer Cells.	Molecular Therapy - Oncolytics	2020
32749622	ASO Author Reflections: Molecular Profiling Can Provide Personalized Clinical Guidance in the Management of Peritoneal Malignancies.	Annals of Surgical Oncology	2020
31160272	Tumour-specific amplitude-modulated radiofrequency electromagnetic fields induce differentiation of hepatocellular carcinoma via targeting Ca<sub>v</sub>3.2â¿¯T-type voltage-gated calcium channels and Ca<sup>2+</sup> influx.	EBioMedicine	2019
31591443	CD138 plasma cells may predict brain metastasis recurrence following resection and stereotactic radiosurgery.	Scientific Reports	2019
31723594	Pleural Effusion Aspirate for use in 3D Lung Cancer Modeling and Chemotherapy Screening.	ACS Biomater Sci Eng	2019
30642553	Feasibility of lung cancer RNA acquisition from a single transbronchial or transthoracic needle pass (FASTT trial).	Lung Cancer	2019
31511892	The nuclear structural protein NuMA is a negative regulator of 53BP1 in DNA double-strand break repair.	Nucleic Acids Res	2019
31033233	Dissecting intratumoral myeloid cell plasticity by single cell RNA-seq.	Cancer Med	2019
30812030	The nuclear structural protein NuMA is a negative regulator of 53BP1 in DNA double-strand break repair.	Nucleic Acids Res	2019
30854931	Identification of CD37, cystatin A, and IL-23A gene expression in association with brain metastasis: analysis of a prospective trial.	International Journal of Biological Markers	2019
29330212	Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014.	Oncologist	2018
30076241	CD38 Inhibits Prostate Cancer Metabolism and Proliferation by Reducing Cellular NAD<sup>+</sup> Pools.	Mol Cancer Res	2018
30158830	Addressing the Adult Soft Tissue Sarcoma Microenvironment with Intratumoral Immunotherapy.	Sarcoma	2018
30386679	Tumor mutational burden is a determinant of immune-mediated survival in breast cancer.	Oncoimmunology	2018
30094640	Glioblastoma radiomics: can genomic and molecular characteristics correlate with imaging response patterns?	Neuroradiology	2018
29568403	Exosomal microRNA profiling to identify hypoxia-related biomarkers in prostate cancer.	Oncotarget	2018
29437791	A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia.	Clin Cancer Res	2018
29216340	Incorporating blood-based liquid biopsy information into cancer staging: time for a TNMB system?	Ann Oncol	2018
27821631	<i>APOL1</i> Renal-Risk Variants Induce Mitochondrial Dysfunction.	J Am Soc Nephrol	2017